The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...

Symptoms include difficulty breathing, swelling of the face and throat, rapid heartbeat, low blood pressure, gastrointestinal (GI) distress, and skin reactions like hives or itching. Anaphylaxis ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is associated with a risk for anaphylaxis and issued a new boxed warning, ...

The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any ...

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after the first dose or following doses administered years after starting the medi ...

They may have difficulty breathing, flushed or paler skin and a visibly swollen tongue or throat. they might be confused or feel very scared ... Call 999 if you spot these symptoms. Anaphylaxis (also ...